IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary ex...
Saved in:
| Main Authors: | V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2018-02-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS
by: V. K. Fedyaeva, et al.
Published: (2017-08-01) -
MARKET ECONOMICS PRICING PARTICULARS
by: V. I. Parshin
Published: (2016-12-01) -
THE STUDY OF PRICING IN THE SPHERE OF EDUCATIONAL SERVICES (ON THE EXAMPLE OF THE REPUBLIC OF MARI EL)
by: N. G. Ackoraeva, et al.
Published: (2016-12-01) -
Heuristic vs Formalized Pricing in Consumer Markets: The Role of Price Perception Factors
by: V. V. Gerasimenko, et al.
Published: (2025-03-01) -
IMPACT OF THE WORLD PRICES ON THE NATIONAL PRICING SYSTEM
by: Yuri A. Sarukhanyan
Published: (2017-12-01)